BioVentrix has withdrawn its plans to go public, after pitching a Nasdaq IPO earlier this year that aimed to raise about $17 million. In a filing with the SEC, the Massachusetts-based company said the terms of the offering were never set and no securities were sold, following the submission of its S-1 in February. It […]
Initial Public Offering (IPO)
Smart ring maker Oura postpones anticipated IPO
The smart ring maker Oura is putting off its Nasdaq IPO, citing market uncertainty shortly after outlining plans to raise as much as $2.2 billion on a $15 billion valuation. In its announcement of the delay, the company said it is still growing and profitable, with 5.7 million users, and it plans to post 90% […]
Medtronic cuts 2026 guidance on private equity charge related to MiniMed approval
Medtronic (NYSE:MDT) said in an SEC filing that it lowered its full-year guidance after a one-time charge related to its MiniMed diabetes unit. Despite the guidance news filed yesterday, MDT shares are up slightly over the past five days. The S&P 500 is also up a bit. Last week, MiniMed announced FDA clearance for the […]
MiniMed completes $538M IPO, retains $309M in proceeds as Medtronic separation takes shape
MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO). Shares of MMED began trading on Friday, March 6, following the pricing of the IPO that day. They closed today, March 9, down 2.7% at $18 apiece. (Stock markets in general are having a rough week as the Iran war causes […]
MiniMed expects to close $644M IPO next week ahead of Medtronic split
MiniMed has set the price for its planned initial public offering (IPO) ahead of an imminent separation from Medtronic . The Medtronic Diabetes unit’s IPO includes 28 million shares of common stock priced at $20 apiece. Underwriters also have an option to purchase up to 4.2 million additional shares at the same price. Altogether, proceeds […]
Medline announces $3.6B secondary offering from private equity firms
Medline (Nasdaq:MDLN) today announced an underwritten public offering of 75 million shares of its Class A common stock. Certain selling stockholders associated with Blackstone Inc., The Carlyle Group, Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority commenced the offering. It includes a 30-day option to purchase up to […]
3 tips for first-time medtech entrepreneurs from a venture capital pro
Jenny Barba knew there had to be a better way. In the late 1990s, Barba was conducting research, studying potential cures of Parkinson’s, when she asked herself, “Why is this taking so long?” She realized the grant money her lab received wasn’t enough to make an impact at the pace she thought was necessary. So, […]
Medtronic MiniMed Diabetes unit prices IPO at up to $784M
In an amendment to an SEC filing, Medtronic’s Diabetes unit, MiniMed, today priced its planned initial public offering (IPO). Medtronic announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company. In that announcement, the company projected the separation within the next 18 months. It expects to complete the […]
St. Jude Medical founder Manny Villafaña looks to take Medical 21 venture public
Medical 21, the latest venture for a major figure in medtech, has filed a Form S-1 with the U.S. SEC to initiate the process of an initial public offering (IPO). Manny Villafaña founded Medical 21 in 2016, marking his latest venture after leading multiple big names in medtech. He founded CPI, which was acquired by […]
Structural heart treatment developer BioVentrix files for IPO
BioVentrix has filed its Form S-1 with the U.S. SEC to move forward with an initial public offering (IPO). The Mansfield, Massachusetts-based company hopes to get listed on the Nasdaq market under the “BVXX” ticker. While the finances of the proposed IPO weren’t disclosed in the filing, the S-1 outlines an estimated $10 billion U.S. […]
Surgical robot tech developer LivsMed completes Korean IPO worth $94M
LivsMed announced today that it completed an initial public offering worth approximately $94 million on Korea’s KOSDAQ market. Seoul-based LivsMed said its offering drew “significant interest” from major domestic pension funds and institutions and large global financial institutions headquartered in New York and Boston. The company says that its debut as a public company led […]
